Roche (OTCQX:RHHBY) (OTCQX:RHHBF) announced Thursday it has begun discussions with the U.S. government to launch ...

A direct-to-consumer program for its drugs could bring down higher U.S. drug prices while cutting out pharmacy benefit managers.

Roche is considering selling its prescription medicines in the U.S. directly to consumers to lower costs for patients as part ...

The Swiss drugmaker discussed the option of selling drugs directly to patients with U.S. officials following Trump ...

These five blue-chip dividend stocks have had a tough 2025 but are solid long-term buys for growth and income investors.

Roche reported better than expected first-half operating profit, driven by strong sales of breast cancer and asthma ...